The University of Ottawa Heart Institute’s Global Achievement Awards are aimed at recognizing investigators who have made a global impact in his/her sphere of work, or early career investigators who have demonstrated a great potential to become a global leader in their field.
Congratulations to Dr. Rob deKemp and Dr. Emilio Alarcon, recipients of the 2018 Global Achievement Awards.
Dr. Rob deKemp, Scientist
Dr. Rob deKemp is the Head Imaging Physicist, and helped found the National Cardiac PET Centre located at the Institute.
He developed the rubidium PET technology and FlowQuant, the software needed to quantify myocardial blood flow. These technological innovations have patents awarded or pending in 55 countries.
His collaboration with Jubilant DraxImage resulted in the development of RUBY-FILL, a cutting-edge product that enhances how patients with known or suspected coronary artery disease are diagnosed and managed. RUBY-FILL this year received approval from India’s Ministry of Health and is now available on the Indian market. This impactful international collaboration was highlighted by Prime Minister Justin Trudeau of Canada.
Dr. Emilio Alarcon, Scientist
Dr. Emilio Alarcon is widely recognized for his expertise in formulating, developing, and implementing novel bio-materials for the regeneration of the heart, skin, and soft tissues.
He serves as the Chair of two upcoming international symposia: the European Society–International Union for Photobiology World Congress on Light and Life to be held in Barcelona, and the Early Career Investigator Chile and Canada Symposium.
He is the Lead Editor for a new Springer-Nature book on “Nanomaterials for Biomedical Applications”. Emilio is a peer reviewer for numerous agencies including the Canadian Institutes of Health Research (CIHR); the Swiss National Science Foundation; Chile’s National Science and Technology Research Commission (FONDECYT); Argentina’s National Science and Technology Research Commission (FONCYT); and the French National Research Agency.
He has several successful collaborations with international research centres including Sweden; Germany; USA (Harvard Medical School); and Chile. In his lab, Dr. Alarcon hosts international research fellows and most recently, received an award to host a Harvard Medical School researcher as a Visiting Professor.
Dr. Alarcon directs his research team in the Bio-nanomaterials Chemistry and Engineering Laboratory which forms part of the BioEngineering and Therapeutic Solutions (BEaTS) Research Group.
Dr. Alarcon’s research program is funded by CIHR and the Natural Sciences and Engineering Research Council of Canada (NSERC).